MedPath

Pharmaceutical Companies

Galectin Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
14
Market Cap
$163.1M
Website
-
Coherus BioSciences logo

Coherus BioSciences

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2010-01-01
Employees
306
Market Cap
$160.1M
Website
http://www.coherus.com
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by...

BLISS GVS PHARMA LIMITED

๐Ÿ‡ฎ๐Ÿ‡ณIndia
Ownership
-
Established
-
Employees
-
Market Cap
$159.8M
Website
-

Achieve Life Sciences, Inc

๐Ÿ‡จ๐Ÿ‡ฆCanada
Ownership
-
Established
-
Employees
-
Market Cap
$156.5M
Website
-
Ventyx Biosciences logo

Ventyx Biosciences

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2018-01-01
Employees
80
Market Cap
$155.8M
Website
http://www.ventyxbio.com
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1...

TELOMIR PHARMACEUTICALS, INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$155.7M
Website
-
Caprock Mining Corp logo

Caprock Mining Corp

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2005-01-01
Employees
102
Market Cap
$155.6M
Website
http://www.capricor.com
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide,...
OptiNose logo

OptiNose

๐Ÿ‡ณ๐Ÿ‡ดNorway
Ownership
Public
Established
2000-01-01
Employees
132
Market Cap
$155.3M
Website
http://www.optinose.com
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA...

ADVERUM BIOTECHNOLOGIES INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$150.5M
Website
-

Scilex Holding

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
105
Market Cap
$147.5M
Website
-
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product...
ยฉ Copyright 2025. All Rights Reserved by MedPath